Sarasin & Partners LLP
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 31 quarters, returned +0.6% per quarter — versus +2.9% per quarter from simply owning every 13F stock. It beat that baseline in only 38.7% of quarters (excess t = -1.03, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 88 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| NVDA | $793M | | HOLD |
| MSFT | $580M | | TRIM |
| GOOGL | $496M | | TRIM |
| AAPL | $467M | | ADD |
| AMZN | $404M | | TRIM |
| MA | $337M | | TRIM |
| AVGO | $331M | | ADD |
| CME | $275M | | TRIM |
| JPM | $267M | | TRIM |
| NFLX | $238M | | ADD |
| AMGN | $234M | | HOLD |
| BLK | $231M | | TRIM |
| HD | $217M | | TRIM |
| EMR | $216M | | TRIM |
| CL | $213M | | TRIM |
| COST | $200M | | HOLD |
| META | $197M | | TRIM |
| AMT | $149M | | TRIM |
| DUK | $146M | | NEW |
| UBER | $141M | | TRIM |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.